Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

There are few data regarding disparities in overall survival (OS) between Asian and white men with metastatic castration-resistant prostate cancer (mCRPC). We compared OS of Asian and white mCRPC men treated in phase III clinical trials with docetaxel and prednisone (DP) or a DP-containing regimen....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JNCI Cancer Spectr
Autori principali: Halabi, Susan, Dutta, Sandipan, Tangen, Catherine M, Rosenthal, Mark, Petrylak, Daniel P, Thompson, Ian M, Chi, Kim N, De Bono, Johann S, Araujo, John C, Logothetis, Christopher, Eisenberger, Mario A, Quinn, David I, Fizazi, Karim, Morris, Michael J, Higano, Celestia S, Tannock, Ian F, Small, Eric J, Kelly, William Kevin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Brief Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190204/
https://ncbi.nlm.nih.gov/pubmed/32368717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi